Dhampur Bio Organics carries a clean audit record and a straightforward revenue book, but its financial statements are shaped by significant tax and accounting judgements, and a widening set of disputes now exceeds half of the latest year's pre-tax profit. The promoter family is consolidating its hold on the board while public shareholders push back on ESOP and independent-director resolutions.
Key findings
- Disputed demands exceed half of pre-tax profit, led by a new excise claim and a crystallised molasses liability
Major- The company faces aggregate disputed demands above ₹52 crore against a pre-tax profit of ₹45 crore. A new excise demand of ₹14.17 crore on denatured spirit for FY2018-19 to FY2024-25 was disclosed on 1 August 2025 and stayed by the Allahabad High Court the next day. A separate ₹20.30 crore molasses-policy liability crystallised on 28 October 2023, while legacy stamp-duty and environmental-compensation claims of ₹18.01 crore and ₹15.05 crore remain stayed. - A tax-regime election and a land-disposal assumption avoided a ₹15.43 crore deferred-tax charge
Major- Management revised its assumption on disposal of manufacturing land to a slump sale, which changed the tax base and avoided recognising a deferred tax liability of ₹15.43 crore in FY25. The company has also not decided when to opt for the lower-tax regime under Section 115BAA, making deferred-tax measurement a Key Audit Matter, an area requiring the most judgement in the audit. Separately, a ₹1.76 crore insurance claim recognised earlier was written off as an exceptional item in FY25 after the surveyor declined approval. - Promoter family consolidates board control while public shareholders vote against ESOP and independent-director resolutions
Minor- Promoter shareholding held steady at 50.78%, with three family members reclassified to the public category in July 2025. Mr. Gautam Goel was re-designated Chairman and CEO on 31 May 2026, and the company funded a ₹5.50 crore interest-free loan to an employee trust that bought shares for the ESOP scheme. In the May 2025 postal ballot, public institutional shareholders voted unanimously against the ESOP scheme and the re-appointment of two independent directors, though all resolutions passed on promoter votes. - The Singapore subsidiary investment is carried net of a ₹26.38 crore impairment provision
Minor- The investment in wholly owned Dhampur International Pte Ltd. was carried at a gross cost of ₹53.59 crore with an impairment provision of ₹26.38 crore as at 31 March 2023, yielding a net value of ₹27.21 crore. No further impairment charge on this investment, goodwill, or other intangible assets appears in any annual period through FY26. - The Singapore trading subsidiary's revenue collapsed 99.6% while a newly acquired domestic unit more than doubled
Minor- Dhampur International Pte Ltd.'s revenue fell from ₹266.91 crore in FY23 to ₹1.15 crore in FY26. Sonitron Bio Organics, acquired in November 2024 for ₹0.01 crore, grew revenue from ₹0.01 crore in FY24 to ₹149.47 crore in FY26. A Dubai subsidiary was incorporated in May 2026, and the board approved acquiring a third Indian entity on 30 May 2026. - SEBI filing delays attracted fines and a warning letter, and the Income Tax Department searched the premises
Minor- The company paid fines of ₹5,900 each to NSE and BSE in December 2024 for a delayed related-party filing, and ₹59,000 to BSE in July 2025 for a late secretarial compliance report. BSE issued a warning letter on 24 July 2025. The Income Tax Department searched all premises from 29 October to 4 November 2025; as of 20 January 2026, no coercive action had been initiated. - Operating cash flow cumulatively trails EBITDA, and ROCE has declined over four years
Minor- Cumulative cash from operations of ₹370 crore covered only 0.47 times cumulative EBITDA of ₹790 crore over seven years. ROCE fell from 9.61% in FY23 to 4.85% in FY26. The company paid modest dividends of ₹2.50, ₹1.25, and ₹1.50 per share over the last three years and undertook no buybacks. - Revenue recognition is standard, and receivables remain short-cycle through a shift toward lower-margin country liquor
Clean- Revenue is recognised at the point control transfers to the customer, and trade receivables fell to ₹84.94 crore with an 11-day turnover cycle in FY26. Country liquor revenue rose from ₹276 crore in FY23 to ₹1,128 crore in FY26, though its margin was a thin 1.48%.
What to watch
- Excise demand resolution. The ₹14.17 crore excise demand on denatured spirit for FY2018-19 to FY2024-25, stayed by the Allahabad High Court on 2 August 2025.
- Molasses-policy liability. Outcome of the crystallised ₹20.30 crore liability disclosed on 28 October 2023.
- Income-tax search. Outcome of the search conducted 29 October-4 November 2025, with no final order reported as of the FY26 annual report.
- Environmental and stamp-duty appeals. Resolution of the Supreme Court appeals on ₹15.05 crore in environmental compensation and the ₹18.01 crore stamp-duty demand, both stayed as of 19 August 2023.
Bottom line: This is a disclosed record with standard revenue accounting and short-cycle receivables. The weight sits in two places: a contested tax and regulatory docket that exceeds half of pre-tax profit, and accounting judgements that have materially shaped the deferred-tax line. Watch the resolution of the excise and molasses demands, and read the next AGM's voting results for what they say about governance direction.